111 related articles for article (PubMed ID: 17133364)
1. Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells.
Ohashi N; Yaar M; Eller MS; Truzzi F; Gilchrest BA
J Cell Physiol; 2007 Mar; 210(3):582-95. PubMed ID: 17133364
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by telomere 3' overhang-specific DNA.
Eller MS; Puri N; Hadshiew IM; Venna SS; Gilchrest BA
Exp Cell Res; 2002 Jun; 276(2):185-93. PubMed ID: 12027448
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma.
Pitman RT; Wojdyla L; Puri N
Oncotarget; 2013 May; 4(5):761-71. PubMed ID: 23800953
[TBL] [Abstract][Full Text] [Related]
4. Telomere-based DNA damage responses: a new approach to melanoma.
Puri N; Eller MS; Byers HR; Dykstra S; Kubera J; Gilchrest BA
FASEB J; 2004 Sep; 18(12):1373-81. PubMed ID: 15333580
[TBL] [Abstract][Full Text] [Related]
5. Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells.
Yaar M; Eller MS; Panova I; Kubera J; Wee LH; Cowan KH; Gilchrest BA
Breast Cancer Res; 2007; 9(1):R13. PubMed ID: 17257427
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides.
Li GZ; Eller MS; Hanna K; Gilchrest BA
Exp Cell Res; 2004 Dec; 301(2):189-200. PubMed ID: 15530855
[TBL] [Abstract][Full Text] [Related]
7. T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells.
Sarkar S; Faller DV
Oligonucleotides; 2011 Feb; 21(1):47-53. PubMed ID: 21281128
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment.
Weng D; Cunin MC; Song B; Price BD; Eller MS; Gilchrest BA; Calderwood SK; Gong J
Breast Cancer Res; 2010; 12(5):R71. PubMed ID: 20846433
[TBL] [Abstract][Full Text] [Related]
9. Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.
Puri N; Pitman RT; Mulnix RE; Erickson T; Iness AN; Vitali C; Zhao Y; Salgia R
Cancer Lett; 2014 Feb; 343(1):14-23. PubMed ID: 24041868
[TBL] [Abstract][Full Text] [Related]
10. Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells.
Aoki H; Iwado E; Eller MS; Kondo Y; Fujiwara K; Li GZ; Hess KR; Siwak DR; Sawaya R; Mills GB; Gilchrest BA; Kondo S
FASEB J; 2007 Sep; 21(11):2918-30. PubMed ID: 17449721
[TBL] [Abstract][Full Text] [Related]
11. Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA.
Eller MS; Li GZ; Firoozabadi R; Puri N; Gilchrest BA
FASEB J; 2003 Feb; 17(2):152-62. PubMed ID: 12554694
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Action of G-Quadruplex-Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma.
Chhabra G; Wojdyla L; Frakes M; Schrank Z; Leviskas B; Ivancich M; Vinay P; Ganapathy R; Ramirez BE; Puri N
J Invest Dermatol; 2018 Apr; 138(4):903-910. PubMed ID: 29203363
[TBL] [Abstract][Full Text] [Related]
13. ssDNA fragments induce cell senescence by telomere uncapping.
Tsolou A; Passos JF; Nelson G; Arai Y; Zglinicki Tv
Exp Gerontol; 2008 Oct; 43(10):892-9. PubMed ID: 18778766
[TBL] [Abstract][Full Text] [Related]
14. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL
Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043
[TBL] [Abstract][Full Text] [Related]
15. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
16. T-oligo as an anticancer agent in colorectal cancer.
Wojdyla L; Stone AL; Sethakorn N; Uppada SB; Devito JT; Bissonnette M; Puri N
Biochem Biophys Res Commun; 2014 Apr; 446(2):596-601. PubMed ID: 24632202
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N
Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661
[TBL] [Abstract][Full Text] [Related]
18. Fragmentation and rapid shortening of telomere in HeLa cells in the early phase of hydroxyl radical-induced apoptosis.
Shao L; Li QH; Wang J; Tan Z
Cancer Biol Ther; 2005 Mar; 4(3):336-41. PubMed ID: 16210918
[TBL] [Abstract][Full Text] [Related]
19. Telomere length maintenance in aging and carcinogenesis.
Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
[TBL] [Abstract][Full Text] [Related]
20. Cellular senescence, telomere recombination and maintenance.
Yang Q
Cytogenet Genome Res; 2008; 122(3-4):211-8. PubMed ID: 19188689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
